SciELO - Scientific Electronic Library Online

 
vol.21 número2Manual de procedimientos para salas de hospitalización donde se ejecutan ensayos clínicosEfectividad del tratamiento con oleozón versus crema de aloe en la estomatitis subprotésica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Archivo Médico de Camagüey

versión On-line ISSN 1025-0255

Resumen

GONZALEZ REIGADA, Alicia et al. Therapeutic answer in patients who suffers from polycystic ovary syndrome. AMC [online]. 2017, vol.21, n.2, pp. 191-201. ISSN 1025-0255.

Background: polycystic ovary syndrome is an heterogeneous disorder; it has been recognized as the main cause of infertility on women during reproductive ages. Objective: to determine the therapeutic answer on patients who suffers from polycystic ovary syndrome in Camaguey during January 2013 to January 2015. Methods: an observational descriptive and longitudinal study was carried out. The universe was sample by all patients who were diagnosed with polycystic ovary syndrome. The data were processed by descriptive statistics. Results: 66, 97 % of patients answered to the treatment and 70, 00 % of patients who had normoandrogenic type answered correctly too. After the treatment 55, 50 % of patients continuous with ovary volume higher than 13 mL. Conclusions: the most important variation were to reduce blood levels of testosterone and to increase blood levels of progesterone. The therapeutic combination more used was hygienic-dietetic changes plus metformina.

Palabras clave : POLYCYSTIC OVARY SYNDROME [therapy]; PROGESTERONE [therapeutic use]; TREATMENT OUTCOME; INFERTILITY, FEMALE; EPIDEMIOLOGY, DESCRIPTIVE.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License